Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 295–295 | Cite as

Ruxolitinib

Toxoplasmosis and secondary Guillain-Barre syndrome following off-label use: case report
Case report
  • 21 Downloads

Reference

  1. Gonzalez Vicent M, et al. Toxoplasmosis and secondary Guillain-Barre associated with ruxolitinib as graft-versus-host disease treatment. Pediatric Blood and Cancer 66: e27446, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1002/pbc.27446 - Spain

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations